Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Antimicrob Agents Chemother
2015 Aug 01;598:4669-79. doi: 10.1128/AAC.04694-14.
Show Gene links
Show Anatomy links
Characterization of Trypanosoma cruzi Sirtuins as Possible Drug Targets for Chagas Disease.
Moretti NS
,
da Silva Augusto L
,
Clemente TM
,
Antunes RP
,
Yoshida N
,
Torrecilhas AC
,
Cano MI
,
Schenkman S
.
???displayArticle.abstract???
Acetylation of lysine is a major posttranslational modification of proteins and is catalyzed by lysine acetyltransferases, while lysine deacetylases remove acetyl groups. Among the deacetylases, the sirtuins are NAD(+)-dependent enzymes, which modulate gene silencing, DNA damage repair, and several metabolic processes. As sirtuin-specific inhibitors have been proposed as drugs for inhibiting the proliferation of tumor cells, in this study, we investigated the role of these inhibitors in the growth and differentiation of Trypanosoma cruzi, the agent of Chagas disease. We found that the use of salermide during parasite infection prevented growth and initial multiplication after mammalian cell invasion by T. cruzi at concentrations that did not affect host cell viability. In addition, in vivo infection was partially controlled upon administration of salermide. There are two sirtuins in T. cruzi, TcSir2rp1 and TcSir2rp3. By using specific antibodies and cell lines overexpressing the tagged versions of these enzymes, we found that TcSir2rp1 is localized in the cytosol and TcSir2rp3 in the mitochondrion. TcSir2rp1 overexpression acts to impair parasite growth and differentiation, whereas the wild-type version of TcSir2rp3 and not an enzyme mutated in the active site improves both. The effects observed with TcSir2rp3 were fully reverted by adding salermide, which inhibited TcSir2rp3 expressed in Escherichia coli with a 50% inhibitory concentration (IC50) ± standard error of 1 ± 0.5 μM. We concluded that sirtuin inhibitors targeting TcSir2rp3 could be used in Chagas disease chemotherapy.
Abuin,
Expression of trans-sialidase and 85-kDa glycoprotein genes in Trypanosoma cruzi is differentially regulated at the post-transcriptional level by labile protein factors.
1999, Pubmed
Abuin,
Expression of trans-sialidase and 85-kDa glycoprotein genes in Trypanosoma cruzi is differentially regulated at the post-transcriptional level by labile protein factors.
1999,
Pubmed
Alsford,
A sirtuin in the African trypanosome is involved in both DNA repair and telomeric gene silencing but is not required for antigenic variation.
2007,
Pubmed
Amado,
An integrated perspective and functional impact of the mitochondrial acetylome.
2014,
Pubmed
Angelo,
Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects.
2006,
Pubmed
Araya,
Cloning and characterization of a gene for the stage-specific 82-kDa surface antigen of metacyclic trypomastigotes of Trypanosoma cruzi.
1994,
Pubmed
Bitterman,
Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.
2002,
Pubmed
Brachmann,
The SIR2 gene family, conserved from bacteria to humans, functions in silencing, cell cycle progression, and chromosome stability.
1995,
Pubmed
CAMARGO,
GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA.
1964,
Pubmed
Chen,
Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS.
2011,
Pubmed
Choudhary,
Lysine acetylation targets protein complexes and co-regulates major cellular functions.
2009,
Pubmed
Chow,
Promastigote to amastigote differentiation of Leishmania is markedly delayed in the absence of PERK eIF2alpha kinase-dependent eIF2alpha phosphorylation.
2011,
Pubmed
Cornejo,
A novel monoclonal antibody against the C-terminus of β-tubulin recognizes endocytic organelles in Trypanosoma cruzi.
2012,
Pubmed
Cueva,
Posttranslational acetylation of α-tubulin constrains protofilament number in native microtubules.
2012,
Pubmed
Cui,
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach.
2014,
Pubmed
Demir,
Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
2014,
Pubmed
García-Salcedo,
A chromosomal SIR2 homologue with both histone NAD-dependent ADP-ribosyltransferase and deacetylase activities is involved in DNA repair in Trypanosoma brucei.
2003,
Pubmed
Gottlieb,
A new role for a yeast transcriptional silencer gene, SIR2, in regulation of recombination in ribosomal DNA.
1989,
Pubmed
Gottschling,
Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription.
1990,
Pubmed
Gregoretti,
Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.
2004,
Pubmed
Hallows,
Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases.
2006,
Pubmed
Hebert,
Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome.
2013,
Pubmed
Huffman,
SIRT1 is significantly elevated in mouse and human prostate cancer.
2007,
Pubmed
Ivy,
Cloning and characterization of four SIR genes of Saccharomyces cerevisiae.
1986,
Pubmed
Jackson,
Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases.
2003,
Pubmed
Jeffers,
Lysine acetylation is widespread on proteins of diverse function and localization in the protozoan parasite Toxoplasma gondii.
2012,
Pubmed
Kaluarachchi Duffy,
Exploring the yeast acetylome using functional genomics.
2012,
Pubmed
Kim,
Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.
2006,
Pubmed
Landry,
Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
2000,
Pubmed
Lara,
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
2009,
Pubmed
Lin,
Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae.
2000,
Pubmed
Liu,
The critical role of the class III histone deacetylase SIRT1 in cancer.
2009,
Pubmed
Martins,
Starvation and rapamycin differentially regulate host cell lysosome exocytosis and invasion by Trypanosoma cruzi metacyclic forms.
2011,
Pubmed
Massayuki Kikuti,
Divalent metal requirements for catalysis and stability of the RNA triphosphatase from Trypanosoma cruzi.
2006,
Pubmed
Miao,
Extensive lysine acetylation occurs in evolutionarily conserved metabolic pathways and parasite-specific functions during Plasmodium falciparum intraerythrocytic development.
2013,
Pubmed
Michishita,
Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.
2005,
Pubmed
Milne,
The Sirtuin family: therapeutic targets to treat diseases of aging.
2008,
Pubmed
Minucci,
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.
2006,
Pubmed
Newman,
Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease.
2012,
Pubmed
Nogales,
Structural insights into microtubule function.
2000,
Pubmed
Norris,
Acetylation goes global: the emergence of acetylation biology.
2009,
Pubmed
Norvell,
Cell biology. Rise of the rival.
2010,
Pubmed
Park,
SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways.
2013,
Pubmed
Ramirez,
The use of the green fluorescent protein to monitor and improve transfection in Trypanosoma cruzi.
2000,
Pubmed
Rine,
Four genes responsible for a position effect on expression from HML and HMR in Saccharomyces cerevisiae.
1987,
Pubmed
Rondinelli,
Control of tubulin gene expression during metacyclogenesis of Trypanosoma cruzi.
1986,
Pubmed
Rotili,
Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.
2012,
Pubmed
Sacconnay,
Structural insights of SIR2rp3 proteins as promising biotargets to fight against Chagas disease and leishmaniasis.
2013,
Pubmed
Sacconnay,
Computational studies on sirtuins from Trypanosoma cruzi: structures, conformations and interactions with phytochemicals.
2014,
Pubmed
Schenkman,
Attachment of Trypanosoma cruzi to mammalian cells requires parasite energy, and invasion can be independent of the target cell cytoskeleton.
1991,
Pubmed
Schwer,
The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase.
2002,
Pubmed
Schwer,
Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2.
2006,
Pubmed
Seifert,
Chroman-4-one- and chromone-based sirtuin 2 inhibitors with antiproliferative properties in cancer cells.
2014,
Pubmed
Soares,
Anti-Trypanosoma cruzi activity of nicotinamide.
2012,
Pubmed
Strahl,
The language of covalent histone modifications.
2000,
Pubmed
Tan,
Lysine glutarylation is a protein posttranslational modification regulated by SIRT5.
2014,
Pubmed
Tanny,
Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product.
2001,
Pubmed
Tao,
Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress.
2010,
Pubmed
Tavares,
The Leishmania infantum cytosolic SIR2-related protein 1 (LiSIR2RP1) is an NAD+ -dependent deacetylase and ADP-ribosyltransferase.
2008,
Pubmed
Vassilopoulos,
SIRT3 deacetylates ATP synthase F1 complex proteins in response to nutrient- and exercise-induced stress.
2014,
Pubmed
Veiga-Santos,
Inhibition of NAD+-dependent histone deacetylases (sirtuins) causes growth arrest and activates both apoptosis and autophagy in the pathogenic protozoan Trypanosoma cruzi.
2014,
Pubmed
Yoshida,
Metacyclic neutralizing effect of monoclonal antibody 10D8 directed to the 35- and 50-kilodalton surface glycoconjugates of Trypanosoma cruzi.
1989,
Pubmed
Yuan,
The emerging and diverse roles of sirtuins in cancer: a clinical perspective.
2013,
Pubmed
Zemzoumi,
Leishmania major: cell type dependent distribution of a 43 kDa antigen related to silent information regulatory-2 protein family.
1998,
Pubmed
